CN110914408A - 肝类器官组合物以及其制备和使用方法 - Google Patents

肝类器官组合物以及其制备和使用方法 Download PDF

Info

Publication number
CN110914408A
CN110914408A CN201880033510.5A CN201880033510A CN110914408A CN 110914408 A CN110914408 A CN 110914408A CN 201880033510 A CN201880033510 A CN 201880033510A CN 110914408 A CN110914408 A CN 110914408A
Authority
CN
China
Prior art keywords
liver
cells
drug
organoids
organoid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201880033510.5A
Other languages
English (en)
Chinese (zh)
Inventor
武部贵则
筱泽忠纮
小池博之
木村昌树
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Science and Technology Agency
Cincinnati Childrens Hospital Medical Center
Original Assignee
Japan Science and Technology Agency
Cincinnati Childrens Hospital Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Science and Technology Agency, Cincinnati Childrens Hospital Medical Center filed Critical Japan Science and Technology Agency
Publication of CN110914408A publication Critical patent/CN110914408A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/067Hepatocytes
    • C12N5/0671Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37Digestive system
    • A61K35/407Liver; Hepatocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082Supracellular entities, e.g. tissue, organisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/38Vitamins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/119Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/12Hepatocyte growth factor [HGF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/155Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/16Activin; Inhibin; Mullerian inhibiting substance
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20Cytokines; Chemokines
    • C12N2501/237Oncostatin M [OSM]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/38Hormones with nuclear receptors
    • C12N2501/385Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/38Hormones with nuclear receptors
    • C12N2501/39Steroid hormones
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40Regulators of development
    • C12N2501/415Wnt; Frizzeled
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70Enzymes
    • C12N2501/72Transferases (EC 2.)
    • C12N2501/727Kinases (EC 2.7.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999Small molecules not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00Use of cells in diagnostics
    • C12N2503/02Drug screening
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00Supports or coatings for cell culture, characterised by material
    • C12N2533/90Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
CN201880033510.5A 2017-06-09 2018-02-19 肝类器官组合物以及其制备和使用方法 Pending CN110914408A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762517414P 2017-06-09 2017-06-09
US62/517,414 2017-06-09
PCT/US2018/018585 WO2018226267A1 (fr) 2017-06-09 2018-02-19 Compositions d'organoïdes hépatiques et procédés de préparation et d'utilisation correspondants

Publications (1)

Publication Number Publication Date
CN110914408A true CN110914408A (zh) 2020-03-24

Family

ID=64566329

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880033510.5A Pending CN110914408A (zh) 2017-06-09 2018-02-19 肝类器官组合物以及其制备和使用方法

Country Status (10)

Country Link
US (1) US20200199537A1 (fr)
EP (1) EP3635095A4 (fr)
JP (2) JP7148552B2 (fr)
KR (2) KR20240010095A (fr)
CN (1) CN110914408A (fr)
AU (2) AU2018279790B2 (fr)
CA (1) CA3065759A1 (fr)
IL (1) IL270714A (fr)
NZ (1) NZ759164A (fr)
WO (1) WO2018226267A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114317439A (zh) * 2021-12-23 2022-04-12 北京基石生命科技有限公司 一种培养肿瘤类器官的方法
CN117701492A (zh) * 2023-12-14 2024-03-15 首都医科大学 肝类器官的构建方法及其应用

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6804438B2 (ja) 2014-10-17 2020-12-23 チルドレンズ ホスピタル メディカル センター 多能性幹細胞を使用するヒト小腸のin vivoモデル、並びにそれを作製、及び使用する方法
WO2018106628A1 (fr) 2016-12-05 2018-06-14 Children's Hospital Medical Center Organoïdes du côlon et leurs procédés de préparation et d'utilisation
JP2022534397A (ja) * 2019-05-31 2022-07-29 チルドレンズ ホスピタル メディカル センター 造血幹細胞の生成および拡大方法
JP2023516484A (ja) 2020-03-11 2023-04-19 ビット バイオ リミテッド 肝細胞作製方法
US20230399623A1 (en) * 2020-11-13 2023-12-14 Oslo Universitetssykehus Hf Artifical liver organoids and methods of their production
CN112553339A (zh) * 2020-12-29 2021-03-26 广东南芯医疗科技有限公司 伊立替康个体化用药基因的指导方法及试剂盒
EP4352206A2 (fr) * 2021-06-11 2024-04-17 Children's Hospital Medical Center Modèle organoïde hépatique pour l'hyperbilirubinémie et ses procédés de fabrication et d'utilisation
JP2023020221A (ja) * 2021-07-30 2023-02-09 ウシオ電機株式会社 薬剤評価方法
CN114891831A (zh) * 2022-01-14 2022-08-12 北京清华长庚医院 过表达wnt2基因的内皮细胞株及其构建方法和应用
CN115386535B (zh) * 2022-10-26 2023-02-03 天津外泌体科技有限公司 多谱系肝类器官模型及基于该模型的药物肝毒评价方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015183920A2 (fr) * 2014-05-28 2015-12-03 Children's Hospital Medical Center Procédés et systèmes de conversion de cellules précurseurs en tissus gastriques par différenciation dirigée
CN105209605A (zh) * 2013-03-15 2015-12-30 奥加诺沃公司 工程化肝组织、其阵列及其制备方法
WO2016141137A1 (fr) * 2015-03-03 2016-09-09 President And Fellows Of Harvard College Procédés de génération de tissu humain fonctionnel
CN110381967A (zh) * 2016-11-04 2019-10-25 儿童医院医学中心 肝类器官组合物以及其制备和使用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2412800A1 (fr) * 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Organoïde du foie, ses utilisations et son procédé de culture pour l'obtenir
EP2504424A1 (fr) * 2009-11-25 2012-10-03 Institut National De La Sante Et De La Recherche Medicale (Inserm) Procédé de différenciation hépatique de cellules endodermiques définitives
WO2011116930A1 (fr) * 2010-03-22 2011-09-29 Cellartis Ab Différenciation et maturation de cellules pluripotentes en cellules de type hépatocytes par modulation de la voie de signalisation par wnt
TR201104076A1 (tr) * 2011-04-26 2012-11-21 Kordsa Global End�Str�Yel �Pl�K Ve Kord Bez� San. Ve T�C. A.�. Araç lastiği üst kuşak şeridinin üretim yöntemi.
CN107075471A (zh) * 2014-10-08 2017-08-18 新加坡科技研究局 将干细胞分化为肝细胞谱系的方法
US9324528B1 (en) * 2014-11-17 2016-04-26 General Electric Company Magnetic trip mechanism for circuit breaker
WO2017048193A1 (fr) * 2015-09-15 2017-03-23 Agency For Science, Technology And Research (A*Star) Dérivation d'organoïdes hépatiques à partir de cellules souches pluripotentes humaines
CN109153962A (zh) * 2016-03-08 2019-01-04 耶路撒冷希伯来大学的益生研究开发有限公司 连续生物感测的方法及系统

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105209605A (zh) * 2013-03-15 2015-12-30 奥加诺沃公司 工程化肝组织、其阵列及其制备方法
WO2015183920A2 (fr) * 2014-05-28 2015-12-03 Children's Hospital Medical Center Procédés et systèmes de conversion de cellules précurseurs en tissus gastriques par différenciation dirigée
CN106661548A (zh) * 2014-05-28 2017-05-10 儿童医院医疗中心 用于经由定向分化将前体细胞转化为胃组织的方法和系统
WO2016141137A1 (fr) * 2015-03-03 2016-09-09 President And Fellows Of Harvard College Procédés de génération de tissu humain fonctionnel
CN110381967A (zh) * 2016-11-04 2019-10-25 儿童医院医学中心 肝类器官组合物以及其制备和使用方法

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114317439A (zh) * 2021-12-23 2022-04-12 北京基石生命科技有限公司 一种培养肿瘤类器官的方法
CN114317439B (zh) * 2021-12-23 2024-04-16 北京基石生命科技有限公司 一种培养肿瘤类器官的方法
CN117701492A (zh) * 2023-12-14 2024-03-15 首都医科大学 肝类器官的构建方法及其应用

Also Published As

Publication number Publication date
IL270714A (en) 2020-01-30
KR20200015898A (ko) 2020-02-13
AU2022204804A1 (en) 2022-07-28
US20200199537A1 (en) 2020-06-25
AU2018279790A1 (en) 2019-12-05
WO2018226267A1 (fr) 2018-12-13
KR20240010095A (ko) 2024-01-23
JP7148552B2 (ja) 2022-10-05
NZ759164A (en) 2023-02-24
EP3635095A4 (fr) 2021-12-01
JP2022191263A (ja) 2022-12-27
EP3635095A1 (fr) 2020-04-15
JP2020523000A (ja) 2020-08-06
KR102625361B1 (ko) 2024-01-18
AU2018279790B2 (en) 2022-04-07
CA3065759A1 (fr) 2018-12-13

Similar Documents

Publication Publication Date Title
JP7078615B2 (ja) 肝臓オルガノイド組成物ならびにその作製および使用方法
JP7148552B2 (ja) 肝臓オルガノイド組成物ならびにその作製および使用方法
Hogrebe et al. Targeting the cytoskeleton to direct pancreatic differentiation of human pluripotent stem cells
Wang et al. Conversion of human gastric epithelial cells to multipotent endodermal progenitors using defined small molecules
JP6463681B2 (ja) 哺乳類多能性細胞のインビトロでの膵臓への分化
US20160115448A1 (en) Cortical interneurons and other neuronal cells produced by the directed differentiation of pluripotent and multipotent cells
CN110582564A (zh) 从人类多能干细胞衍生肝类器官
JP2020501534A (ja) 結腸オルガノイドならびにその作製方法および使用方法
WO2011009294A1 (fr) Procédés pour obtenir des cellules hépatiques, des cellules d’endoderme hépatiques et des cellules précurseurs hépatiques en induisant la différenciation
JP2005502356A (ja) 治療のための腸内幹細胞の分離、培養および分化方法
US20210180026A1 (en) Hepato-biliary-pancreatic tissues and methods of making same
US20230159887A1 (en) Methods for Generating Thymic Cells in Vitro
Raggi et al. Leveraging interacting signaling pathways to robustly improve the quality and yield of human pluripotent stem cell-derived hepatoblasts and hepatocytes
US20210371815A1 (en) Compositions and methods for obtaining vascularized human intestinal organoid tissue, and related uses thereof
Ori et al. Human pluripotent stem cell fate trajectories toward lung and hepatocyte progenitors
Jenny The generation of human lung progenitors from human embryonic stem cells

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination